“…24,31,33,[35][36][37][38][39] A suitable bifunctional donor, which acts as a bridging ligand, can then coordinate predictably to generate a [2+2] rectangular 2-D architecture. [22][23][24][25][26][27][28][29][30]37 Over the years, metallamacrocyclic supramolecular complexes, containing organometallic rhodium, ruthenium, and iridium half-sandwich fragments, have received a considerable amount of attention due to their myriad of potential applications, 40 including as host-guest, [41][42][43] and drug-delivery systems, [44][45][46][47] and in catalysis. 48 Despite extensive research into the pharmacological activity of small metal-based compounds, investigations into the pharmacological activity of metallosupramolecular coordination compounds have primarily centred on their potential as novel anticancer agents (see selected examples in Fig.…”